Carisma Therapeutics will present at the Chardan 3rd Annual Genetic Medicines Conference being held October 7-8, 2019, at the Westin New York Grand Central in New York City.
Carisma Therapeutics will present at the annual Alliance for Regenerative Medicine (ARM) Cell & Gene Meeting on the Mesa in Carlsbad, CA, October 2-4, 2019.
Michael Klichinsky, VP of Discovery, delivers the Featured Presentation at the inaugural Targeting Innate Immunity Congress: Differentiating Friends from Foes held in Boston, MA, September 24-25, 2019.
"Metastatic solid tumors have been an intractable challenge for engineered cell therapies. Our platform technology, based on the genetically engineered macrophage, has a unique opportunity to provide benefit in this disease state," said Dr. Michael Klichinsky, co-Founder and Vice President of Discovery at Carisma.
Michael Klichinsky, co-founder and VP of Discovery, to discuss why Carisma's CAR Macrophages are tailor-made for solid tumor immunotherapy on Friday, September 13 at 12, noon, at the Seaport World Trade Center in Boston.
Carisma's VP of Discovery Research, Michael Klichinsky, presents at the CAR and T cell therapies: Pioneering point of care with innovative manufacturing and commercialization strategies meeting in San Francisco, CA, June 18-20, 2019.